CONRIG PHARMA ApS: Financial statements 2020
CVR: 33373236
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CONRIG PHARMA ApS (CVR 33373236) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -555,136 and a net result of DKK -603,545 compared with DKK -198,499 the year before. Equity in the 2020 report amounted to DKK -1,396,615.
- Gross Profit
- DKK -555,136
- Profit/Loss
- DKK -603,545
- Equity
- DKK -1,396,615
- Total Assets
- DKK 249,782
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -555 t. | -604 t. | -1.4 mio. | - |
| 2019 | - | -165 t. | -198 t. | -793 t. | - |
| 2018 | - | -388 t. | -398 t. | -595 t. | - |
| 2017 | - | -305 t. | -286 t. | -197 t. | - |
| 2016 | - | -684 t. | -531 t. | 90 t. | - |
How creditworthy is CONRIG PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
CONRIG PHARMA ApS has published its annual report for 2019. Gross profit came to DKK -165,433, and the net result was DKK -198,499.
About CONRIG PHARMA ApS
CONRIG PHARMA ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Snickar Karl Johan Tobieson and Lars Christer Fredrik Fåhraeus. The company is owned by Melius Pharma AB. The company has 0 employees (2011). In 2025, the company reported a gross profit of DKK -98,936 and a net result of DKK -95,786 compared with DKK -100,217 the year before. Equity in the 2025 report amounted to DKK 0.